CompoAtlas

BIONATURE - INCREDIBLE HAIR

Food supplement declared in France, declaration No 2024-2-1382, decision dated 22 February 2024

BIONATURE - INCREDIBLE HAIR, from EMMEBI ITALIA SRL, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Aristotelia chilensis 20 mg per day, Panicum miliaceum 20 mg per day, Rosmarinus officinalis 1 mg per day, Pantothenic acid (vitamin B5), Biotin (vitamin B8). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
EMMEBI ITALIA SRL
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Tablet
Daily dose
1 comprime
Directions for use
PRENDRE UN COMPRIMÉ PAR JOUR AU PETIT DÉJEUNER, AVEC UN GRAND VERRE D'EAU.
Not recommended (according to the manufacturer)
Adolescents (under 18), Taking medication
Objectives stated by the manufacturer (these are not authorised claims)
Hair and nails

Declaration 270799, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Aristotelia chilensis (Molina) StuntzFruitAutre extrait sec20 mg
Panicum miliaceum L.GraineAutre extrait sec20 mg
Rosmarinus officinalis L.Essence (feuille)Distillation1 mg

Other active ingredients

NamePer day
Oligo-proanthocyanidinesnot declared
Méthylsulfonate de méthanenot declared
Lysinenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
D-pantothenate, calciumPantothenic acid (vitamin B5)no limit (insufficient data)dose annulled by the French Council of State in 2011
D-biotinBiotin (vitamin B8)no limit (insufficient data)dose annulled by the French Council of State in 2011
cupric sulphateCopper5,000 µg2,000 µg
ferrous fumarateIron40 mg (safe level)14 mg
pteroylmonoglutamic acidFolate (vitamin B9)1,000 µg200 µg
Molybdate de sodiumMolybdenum600 µg150 µg
nicotinamideNicotinamide (vitamin B3)900 mg54 mg
sodium seleniteSelenium255 µg50 µg
thiamin hydrochlorideVitamin B1 (thiamine)no limit (insufficient data)dose annulled by the French Council of State in 2011
L-ascorbic acidVitamin Cno limit (insufficient data)180 mg
DL-alpha-tocopheryl acetateVitamin E300 mg30 mg
zinc sulphateZinc25 mg15 mg

Additives

E460, E341, E464, E920, E551, E470b, E468

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

NE PAS DÉPASSER LA DOSE JOURNALIÈRE RECOMMANDÉE.TENIR HORS DE PORTÉE DES JEUNES ENFANTS. LES COMPLÉMENTSALIMENTAIRES NE DOIVENT PAS ÊTRE UTILISÉS COMME SUBSTITUT D’UNEALIMENTATION VARIÉE ET ÉQUILIBRÉE ET D’UN MODE DE VIE SAIN. DÉCONSEILLÉAUX PERSONNES SOUFFRANT DE MALADIES AYANT POUR CONSÉQUENCE UNEACCUMULATION ANORMALE DE FER (HÉMOCHROMATOSE, POLYGLOBULIE…).EN CAS DE TRAITEMENT MÉDICAMENTEUX CONCOMITANT, DEMANDER CONSEILÀ UN PROFESSIONNEL DE SANTÉ. IL EST DÉCONSEILLÉ AUX FEMMES ENCEINTESET ALLAITANTES; ÉVITER DE CONSOMMER EN CAS D’OBSTRUCTION BILIAIRE OUD’AUTRES TROUBLES DE LA FONCTION BILIAIRE ET AVANT L’ÂGE DE 18 ANS.RÉSERVÉ À L’ADULTE. ÉVITER DE CONSOMMER LE PRODUIT DE MANIÈREPROLONGÉE (PAS PLUS DE 14 JOURS).

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Rosmarinus officinalis L.
    Read the warning, when it applies and the studies cited

    ROSEMARY – ROSMARINUS OFFICINALIS Oral

    Route of administration: Oral (ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).

    Sources cited by Health Canada (4)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association’s Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.

    Health Canada monograph dated 29 May 2026

    ROSEMARY - ROSMARINUS OFFICINALIS Topical

    Route of administration: Topical (ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).

    Sources cited by Health Canada (4)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association’s Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have large open wounds, skin lesions, feverish conditions, acute inflammation, severe circulatory disorders or hypertension (ESCOP 2003).

    Sources cited by Health Canada (1)
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Barnes et al. 2007; ESCOP 2003).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Health Canada monograph dated 29 May 2026

  • Méthylsulfonate de méthane
    Read the warning, when it applies and the studies cited

    MSM

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Known adverse reactions

    When using this product you may experience gastrointestinal discomfort/disturbances (Kim et al. 2005).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

  • Lysine
    Read the warning, when it applies and the studies cited

    LYSINE

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing more than 300 mg of lysine, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Goldman and Ausiello 2004).

    Sources cited by Health Canada (1)
    • Goldman L, Ausiello D, editors. Cecil Textbook of Medicine, Volume 1, 22nd edition. Philadelphia (PA): Saunders; 2004.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “BIONATURE - INCREDIBLE HAIR: composition and regulation”, https://compoatlas.com/en/supplements/products/270799-bionature-incredible-hair, updated 15 November 2026.

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line